» Articles » PMID: 22149740

Faecal Haemoglobin Concentrations by Gender and Age: Implications for Population-based Screening for Colorectal Cancer

Overview
Specialties Biochemistry
Pathology
Date 2011 Dec 14
PMID 22149740
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Faecal immunochemical tests (FIT) are becoming widely used in colorectal cancer screening. Estimation of faecal haemoglobin concentration in a large group prompted an observational study on gender and age.

Methods: A single estimate of faecal haemoglobin concentration was made using quantitative automated immunoturbidimetry. Potential reference intervals were calculated for men and women and for age quintiles according to the Clinical and Laboratory Standards Institute Approved Guideline. The percentages of positive results were calculated at a number of concentrations. The percentages of individuals who fell into different risk groups were assessed.

Results: The 97.5 percentiles, potential upper reference limits, were 519 ng haemoglobin/mL (90% CI: 468-575) for men and 283 ng haemoglobin/mL (90% CI: 257-316) for women. Concentrations increased with age in both genders. Decision limits have advantages over reference intervals. At any cut-off concentration, more men are declared positive than women and more older people are declared positive than younger people. Future risk of neoplasia is higher in men than in women and in older people.

Conclusions: Faecal haemoglobin concentrations vary with gender and age. More tailored strategies are needed in screening programmes. Faecal haemoglobin concentration could be included in individual risk assessment scores. These data should assist in screening programme design.

Citing Articles

Negative predictive value of fecal immunochemical testing in significant bowel disease screening: a systematic review and meta-analysis.

Junhai Z, Fei L, Jixiang Z, Huabing X, Cheng T, Weiguo D Int J Surg. 2024; 111(1):1182-1190.

PMID: 38920326 PMC: 11745644. DOI: 10.1097/JS9.0000000000001844.


Diagnostic accuracy of risk assessment and fecal immunochemical test in colorectal cancer screening: Results from a population-based program and meta-analysis.

Wang Z, Teng J, Wu W, Dou J, Wong M, Gong Y Cancer Med. 2023; 12(17):18189-18200.

PMID: 37578430 PMC: 10524075. DOI: 10.1002/cam4.6399.


Interval cancers in a national colorectal screening programme based on faecal immunochemical testing: Implications for faecal haemoglobin concentration threshold and sex inequality.

Clark G, Godfrey T, Purdie C, Strachan J, Carey F, Fraser C J Med Screen. 2023; 31(1):21-27.

PMID: 37469171 PMC: 10878005. DOI: 10.1177/09691413231188252.


Improved use of faecal immunochemical tests for haemoglobin in the Scottish bowel screening programme.

Digby J, Fraser C, Clark G, Mowat C, Strachan J, Steele R J Med Screen. 2023; 30(4):184-190.

PMID: 37229658 PMC: 10629250. DOI: 10.1177/09691413231175611.


Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT).

Breekveldt E, Toes-Zoutendijk E, de Jonge L, Spaander M, Dekker E, van Kemenade F BMC Gastroenterol. 2023; 23(1):45.

PMID: 36814185 PMC: 9948315. DOI: 10.1186/s12876-023-02670-1.